Daniel Lang - Pres Cell Therapy, VP Corp Dev at Athenex, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Pres Cell Therapy, VP Corp Dev
Stock Symbol
ATNXQ
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Daniel Lang since 12/23/2023

Holdings reported by Daniel Lang for Athenex, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 81.6K $111K $1.36 Sep 16, 2022 Direct
Stock Option (Right to Buy) 200K Sep 16, 2022 Direct Common Stock 200K
Restricted Stock Units 37.5K Sep 16, 2022 Direct Common Stock

Transactions reported by Daniel Lang for Athenex, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.